Delivery Order SPE2DB20D3101-SPE2DB24FRTS0
Award Date
9/3/24
Potential Completion Date
9/24/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,565.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024, with a completion date of September 30, 2024. The contract has no set-aside designation. As a large supplier of pharmaceuticals and medical supplies to the U.S. federal government, Amerisourcebergen holds...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,835.28 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 20, 2025, with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The $1,188.34 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 14, 2024, with a completion date of September 5, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award is a delivery order valued at $4,917.64, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a performance period extending through May 23, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. The fixed-price contract, valued at $2,458.82, has an ultimate completion date of April 3, 2025. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,565.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, to support various government agencies and healthcare programs. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $3,565.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical product, with a period of performance ending on December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $22,129.38 and runs through April 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $4,753.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The award has an ultimate completion date of November 12, 2024 and a firm fixed price pricing type. This contract is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. This is a Firm Fixed Price delivery order contract that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen...